These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6241304)

  • 1. [Prognostic value of serum CEA and therapy-induced nonspecific CEA levels in metastasizing breast carcinoma].
    Treidler J; Pompecki R; Müllerleile U; Garbrecht M; Kleeberg UR
    Onkologie; 1984 Dec; 7(6):328-33. PubMed ID: 6241304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of hormone therapy in metastasizing breast cancer].
    Samonigg H
    Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
    Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA
    Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study].
    Wander HE; Kleeberg UR; Essers U; Blossey HC; Nagel GA
    Onkologie; 1987 Oct; 10(5):321-3. PubMed ID: 2960938
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
    Loprinzi CL; Tormey DC; Rasmussen P; Falkson G; Davis TE; Falkson HC; Chang AY
    J Clin Oncol; 1986 Jan; 4(1):46-56. PubMed ID: 3510282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)].
    Pompecki R; Schröder G; Garbrecht M; Frahm H
    Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic validity of CEA determination in metastasizing breast cancer].
    Krieger G; Prangen M; Klar R; Kneba M; Bandlow G; Nagel GA
    Klin Wochenschr; 1986 Aug; 64(15):701-7. PubMed ID: 3762017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy.
    Theriault RL; Hortobagyi GN; Fritsche HA; Frye D; Martinez R; Buzdar AU
    Cancer; 1989 Mar; 63(5):828-35. PubMed ID: 2914290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen.
    Silva JS; Leight GS; Haagensen DE; Tallos PB; Cox EB; Dilley WG; Wells SA
    Cancer; 1982 Mar; 49(6):1236-42. PubMed ID: 6174201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medroxyprogesterone acetate (MAP) and aminoglutethimide (AG) in metastatic breast carcinoma. Preliminary report on a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
    Wander HE; Nagel GA; Blossey HC
    Onkologie; 1982 Aug; 5 Suppl():28-33. PubMed ID: 6215600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer.
    Mughal AW; Hortobagyi GN; Fritsche HA; Buzdar AU; Yap HY; Blumenschein GR
    JAMA; 1983 Apr; 249(14):1881-6. PubMed ID: 6834584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal control of disseminated breast cancer].
    Voznyĭ EK; Meshcheriakova NG; Biakhov MIu; Vasiuta NIu
    Sov Med; 1990; (6):94-7. PubMed ID: 2144368
    [No Abstract]   [Full Text] [Related]  

  • 13. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
    Staab HJ; Ahlemann LM; Koch HL; Anderer FA
    Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic breast cancer with constantly low CEA blood levels. A subgroup with unfavorable prognosis?
    Krieger G; Wander HE; Kneba M; Prangen M; Bandlow G; Nagel GA
    J Cancer Res Clin Oncol; 1984; 108(3):341-4. PubMed ID: 6511807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.
    Falkson HC; Van Der Watt JJ; Portugal MA; Pitout MJ; Falkson G
    Cancer; 1978 Sep; 42(3):1308-13. PubMed ID: 698917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relation between serum carcinoembryonic antigen (CEA) and response to chemotherapy in patients with advanced colorectal cancer].
    Shimano T; Monden T; Morimoto H; Mori T
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):423-8. PubMed ID: 2321973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of serial carcinoembryonic antigen (CEA) determinations in monitoring chemotherapy.
    Young VL; Kashmiri R; Hazen ZR; Meeker WR
    South Med J; 1976 Oct; 69(10):1274-6. PubMed ID: 982100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
    Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol.
    Van Deijk WA; Blijham GH; Mellink WA; Meulenberg PM
    Cancer Treat Rep; 1985 Jan; 69(1):85-90. PubMed ID: 3155651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radioimmunoassay of carcinoembryonic antigen in the evaluation of the effectiveness of breast cancer treatment].
    Polevaia EB; Ivanov VM; Koposova TL; Gabuniia RI; Chinareva IV
    Vopr Onkol; 1984; 30(4):23-9. PubMed ID: 6730403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.